Inozyme Pharma Stock Forecast

Stock Price Forecast

The 9 analysts with 12-month price forecasts for Inozyme Pharma stock had an average target of $15.22, with a low estimate of $4.00 and a high estimate of $30.

Price Target: $15.22 (+280.50%)

Analyst Consensus: Buy

Price Target

Target	Low	Average	Median	High
Price	$4.00	$15.22	n/a	$30
Change	0.00%	+280.50%	n/a	+650.00%

Analyst Ratings

The average analyst rating for Inozyme Pharma stock from 9 stock analysts was "Buy". This means that analysts believed this stock was likely to outperform the market over the next twelve months.

Recommendation Trends

No data available

Rating	Oct 2026
Strong Buy	n/a
Buy	n/a
Hold	n/a
Sell	n/a
Strong Sell	n/a
Total	n/a

Financial Forecast

Revenue This Year

n/a

from 191.73M

Revenue Next Year

n/a

EPS This Year

-1.46

from -1.62

EPS Next Year

-1.17

from -1.46

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027	FY 2028	FY 2029
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027	Dec 31, 2028	Dec 31, 2029
EPS	-5.11	-2.40	-1.78	-1.37	-1.62	-1.46	-1.17
No. Analysts	-	-	-	-	-	11	11

Revenue Forecast

Revenue	2025	2026
High	n/a	7.8M
Avg	n/a	1.1M
Low	n/a	n/a

Revenue Growth

Revenue Growth	2025	2026
High	-	-
Avg	-	-
Low	-	-

EPS Forecast

EPS	2025	2026
High	-1.22	-0.80
Avg	-1.46	-1.17
Low	-1.61	-1.47

EPS Growth

EPS Growth	2025	2026
High	-	-
Avg	-	-
Low	-	-